BRG1 Increases Melanoma Invasiveness
Author Information
Author(s): Saladi Srinivas Vinod, Keenen Bridget, Marathe Himangi G, Qi Huiling, Chin Khew-Voon, de la Serna Ivana L
Primary Institution: University of Toledo College of Medicine
Hypothesis
Does BRG1 expression influence melanoma invasiveness through modulation of extracellular matrix and adhesion molecules?
Conclusion
Increased BRG1 levels promote the epigenetic changes in gene expression required for melanoma metastasis.
Supporting Evidence
- BRG1 mRNA levels were significantly higher in stage IV melanomas compared to stage III tumors and normal skin.
- Expression of BRG1 in melanoma cells that lack BRG1 increased invasive ability.
- Down-regulation of BRG1 inhibited invasive ability in vitro.
Takeaway
This study found that a protein called BRG1 helps melanoma cells become more invasive, which means they can spread more easily in the body.
Methodology
The study used quantitative PCR to measure BRG1 expression in melanoma samples and cell lines, and performed invasion assays to assess the invasive ability of melanoma cells.
Potential Biases
Potential bias in sample selection and the reliance on specific cell lines may affect the generalizability of the findings.
Limitations
The study may not account for all factors influencing melanoma invasiveness, and results are based on in vitro experiments.
Participant Demographics
The study involved patient-derived melanoma specimens from various stages, including normal skin, stage III, and stage IV melanoma.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website